Researchers develop new antibody with potential to treat several types of cancer

Researchers at Uppsala University and KTH Royal Institute of Technology have developed a new form of precision medicine, an antibody, with the potential to treat several types of cancer.

Shorter TB Treatment Recommended for Kids, Adults

Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children. Updated joint guidelines from the American Thoracic Society,

January 11, 2025

FDA rejects Coherus’ reworked Neulasta biosimilar due to third-party inspections

The FDA has rejected Coherus BioSciences’ new presentation for its Udenyca (pegfilgrastim-cbqv) biosimilar due to an inspection at one of its contractors. Coherus said the

September 26, 2023

A French startup wants to decentralize cell and gene therapy manufacturing, making it ‘the size of a book’

Jérémie Laurent stumbled into biology. While studying aerospace engineering, all of Laurent’s classes were about math, so he began taking biology classes as an escape.

June 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.